Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
We assessed if immune responses are enhanced in CD-1 mice by heterologous vaccination with two different nucleic acid-based COVID-19 vaccines: a next-generation human adenovirus serotype 5 (hAd5)-vectored dual-antigen spike (S) and nucleocapsid (N) vaccine (AdS+N) and a self-amplifying and -adjuvant...
Main Authors: | Adrian Rice, Mohit Verma, Emily Voigt, Peter Battisti, Sam Beaver, Sierra Reed, Kyle Dinkins, Shivani Mody, Lise Zakin, Shiho Tanaka, Brett Morimoto, C. Anders Olson, Elizabeth Gabitzsch, Jeffrey T. Safrit, Patricia Spilman, Corey Casper, Patrick Soon-Shiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.910136/full |
Similar Items
-
Ethical concerns regarding heterologous COVID-19 vaccine administration
by: Somsri Wiwanitkit, et al.
Published: (2024-12-01) -
Research Progress in Heterologous Crocin Production
by: Junjie Zhou, et al.
Published: (2023-12-01) -
Assessment on Different Vaccine Formulation Parameters in the Protection against Heterologous Challenge with FMDV in Cattle
by: Sebastián Di Giacomo, et al.
Published: (2022-08-01) -
Recent Advances in the Heterologous Expression of Biosynthetic Gene Clusters for Marine Natural Products
by: Yushan Xu, et al.
Published: (2022-05-01) -
Ultrastructural study on experimental infection of rotavirus in a murine heterologous model
by: Selma Majerowicz, et al.
Published: (1994-09-01)